|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 283.40 INR | +0.25% |
|
-2.34% | -28.69% |
| 11-13 | Jyothy Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 | CI |
| 12-05 | Jyothy Labs Limited, Q2 2026 Earnings Call, Nov 12, 2025 |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.02 | 6.33 | 8.5 | 12.49 | 11.67 | |||||
Return on Total Capital | 11.06 | 8.04 | 10.95 | 16.11 | 14.96 | |||||
Return On Equity % | 14.72 | 11.39 | 16.23 | 21.97 | 19.19 | |||||
Return on Common Equity | 15.01 | 11.28 | 16.02 | 22.01 | 19.2 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 46.7 | 41.23 | 41.94 | 48.82 | 50.15 | |||||
SG&A Margin | 18.76 | 18.71 | 17.74 | 19.24 | 19.84 | |||||
EBITDA Margin % | 16.16 | 10.89 | 12.36 | 17.16 | 17.61 | |||||
EBITA Margin % | 14.33 | 9.17 | 11.17 | 16.14 | 16.57 | |||||
EBIT Margin % | 14.33 | 9.17 | 11.17 | 16.14 | 16.57 | |||||
Income From Continuing Operations Margin % | 9.98 | 7.24 | 9.64 | 13.38 | 12.91 | |||||
Net Income Margin % | 10.44 | 7.37 | 9.64 | 13.38 | 12.91 | |||||
Net Avail. For Common Margin % | 10.44 | 7.37 | 9.64 | 13.38 | 12.91 | |||||
Normalized Net Income Margin | 8.93 | 5.69 | 6.89 | 10.53 | 10.74 | |||||
Levered Free Cash Flow Margin | 14.19 | 4.87 | 8.7 | 11.8 | 6.55 | |||||
Unlevered Free Cash Flow Margin | 14.8 | 5.2 | 9.03 | 11.9 | 6.68 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.01 | 1.1 | 1.22 | 1.24 | 1.13 | |||||
Fixed Assets Turnover | 5.11 | 6.23 | 7.33 | 8.05 | 7.99 | |||||
Receivables Turnover (Average Receivables) | 17.62 | 18.5 | 17.7 | 16.26 | 11.97 | |||||
Inventory Turnover (Average Inventory) | 4.04 | 4.48 | 4.82 | 4.83 | 4.68 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.32 | 1.39 | 1.91 | 2.37 | 2.76 | |||||
Quick Ratio | 0.61 | 0.69 | 1.03 | 1.69 | 2.03 | |||||
Operating Cash Flow to Current Liabilities | 0.85 | 0.39 | 0.81 | 0.95 | 0.61 | |||||
Days Sales Outstanding (Average Receivables) | 20.72 | 19.73 | 20.62 | 22.52 | 30.5 | |||||
Days Outstanding Inventory (Average Inventory) | 90.3 | 81.41 | 75.73 | 75.8 | 78.06 | |||||
Average Days Payable Outstanding | 54.8 | 59.7 | 56.8 | 64.34 | 70.11 | |||||
Cash Conversion Cycle (Average Days) | 56.22 | 41.43 | 39.55 | 33.97 | 38.45 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 11.97 | 12.21 | 3 | 2.79 | 2.99 | |||||
Total Debt / Total Capital | 10.69 | 10.88 | 2.91 | 2.72 | 2.9 | |||||
LT Debt/Equity | 2.1 | 1.75 | 1.81 | 1.43 | 1.78 | |||||
Long-Term Debt / Total Capital | 1.87 | 1.56 | 1.75 | 1.39 | 1.73 | |||||
Total Liabilities / Total Assets | 28.9 | 30.64 | 24.77 | 24.6 | 23.83 | |||||
EBIT / Interest Expense | 14.65 | 17.12 | 21.32 | 94.24 | 80.14 | |||||
EBITDA / Interest Expense | 17.55 | 21.96 | 25.09 | 104.57 | 89.42 | |||||
(EBITDA - Capex) / Interest Expense | 16.16 | 19.74 | 22.37 | 96.73 | 79.62 | |||||
Total Debt / EBITDA | 0.51 | 0.66 | 0.14 | 0.1 | 0.12 | |||||
Net Debt / EBITDA | -0.08 | -0.15 | -0.71 | -1.13 | -1.3 | |||||
Total Debt / (EBITDA - Capex) | 0.55 | 0.74 | 0.16 | 0.11 | 0.13 | |||||
Net Debt / (EBITDA - Capex) | -0.08 | -0.16 | -0.79 | -1.22 | -1.45 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 11.58 | 15.03 | 13.18 | 11.06 | 3.88 | |||||
Gross Profit, 1 Yr. Growth % | 11.31 | 1.57 | 15.11 | 29.31 | 6.73 | |||||
EBITDA, 1 Yr. Growth % | 25.59 | -22.53 | 28.49 | 53.59 | 6.63 | |||||
EBITA, 1 Yr. Growth % | 28.13 | -26.4 | 37.94 | 59.84 | 6.62 | |||||
EBIT, 1 Yr. Growth % | 28.16 | -26.41 | 37.96 | 59.84 | 6.61 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 17.27 | -16.53 | 50.65 | 54.05 | 0.29 | |||||
Net Income, 1 Yr. Growth % | 17.09 | -18.79 | 48.01 | 54.11 | 0.27 | |||||
Normalized Net Income, 1 Yr. Growth % | 34.28 | -26.67 | 36.94 | 69.72 | 5.97 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 17.06 | -18.78 | 48.04 | 54.09 | 0.28 | |||||
Accounts Receivable, 1 Yr. Growth % | -22.91 | 51.65 | -3.68 | 46.14 | 36.27 | |||||
Inventory, 1 Yr. Growth % | 23.8 | 6.67 | 1.56 | -6.08 | 15.71 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -4.1 | -7.29 | 0.06 | 2.2 | 7.01 | |||||
Total Assets, 1 Yr. Growth % | 6.52 | 3.41 | 1.92 | 16.45 | 12.07 | |||||
Tangible Book Value, 1 Yr. Growth % | 46.08 | 2.48 | 15.8 | 34.37 | 23.65 | |||||
Common Equity, 1 Yr. Growth % | 16.27 | 1.05 | 7.3 | 16.74 | 13.34 | |||||
Cash From Operations, 1 Yr. Growth % | 134.53 | -49.63 | 62.23 | 39.33 | -31.99 | |||||
Capital Expenditures, 1 Yr. Growth % | -38.35 | 0.59 | 36.19 | 4.54 | 56.73 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 273.89 | -60.54 | 110.95 | 50.08 | -42.34 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 218.6 | -59.57 | 104.24 | 45.96 | -41.73 | |||||
Dividend Per Share, 1 Yr. Growth % | 33.33 | -37.5 | 20 | 16.67 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.6 | 13.29 | 14.1 | 12.11 | 7.41 | |||||
Gross Profit, 2 Yr. CAGR % | 3.35 | 6.33 | 8.13 | 21.98 | 17.48 | |||||
EBITDA, 2 Yr. CAGR % | 1.62 | -1.36 | -0.23 | 40.74 | 27.97 | |||||
EBITA, 2 Yr. CAGR % | 0.76 | -2.89 | 0.76 | 48.79 | 30.55 | |||||
EBIT, 2 Yr. CAGR % | 0.77 | -2.88 | 0.76 | 48.8 | 30.54 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -1.77 | -1.07 | 12.13 | 52.34 | 24.3 | |||||
Net Income, 2 Yr. CAGR % | -1.38 | -2.49 | 9.63 | 51.03 | 24.31 | |||||
Normalized Net Income, 2 Yr. CAGR % | 2.11 | -0.77 | 0.21 | 52.45 | 34.11 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -1.7 | -2.5 | 9.65 | 51.04 | 24.31 | |||||
Accounts Receivable, 2 Yr. CAGR % | -21.57 | 8.13 | 20.86 | 18.64 | 41.12 | |||||
Inventory, 2 Yr. CAGR % | 17.36 | 14.92 | 4.08 | -2.34 | 4.25 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 6.52 | -5.7 | -3.68 | 1.13 | 4.58 | |||||
Total Assets, 2 Yr. CAGR % | 0.35 | 4.96 | 2.67 | 8.95 | 14.24 | |||||
Tangible Book Value, 2 Yr. CAGR % | 9.26 | 22.35 | 8.94 | 24.74 | 28.9 | |||||
Common Equity, 2 Yr. CAGR % | 3.77 | 8.39 | 4.13 | 11.92 | 15.03 | |||||
Cash From Operations, 2 Yr. CAGR % | 15.49 | 8.69 | -9.61 | 50.36 | -2.66 | |||||
Capital Expenditures, 2 Yr. CAGR % | -19.47 | -21.25 | 17.04 | 19.32 | 28 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 29.94 | 21.46 | -10.67 | 78.22 | -6.98 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 26.27 | 13.49 | -10.9 | 72.94 | -7.78 | |||||
Dividend Per Share, 2 Yr. CAGR % | 15.47 | -8.71 | -13.4 | 18.32 | 8.01 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.51 | 6.58 | 13.26 | 13.07 | 9.3 | |||||
Gross Profit, 3 Yr. CAGR % | 4.24 | 2.75 | 9.18 | 14.76 | 16.67 | |||||
EBITDA, 3 Yr. CAGR % | 4.54 | -7.17 | 7.72 | 15.34 | 28.3 | |||||
EBITA, 3 Yr. CAGR % | 4.45 | -9.26 | 9.16 | 17.67 | 33.14 | |||||
EBIT, 3 Yr. CAGR % | 4.47 | -9.26 | 9.17 | 17.67 | 33.15 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 2.15 | -6.96 | 13.82 | 24.66 | 32.53 | |||||
Net Income, 3 Yr. CAGR % | 2.34 | -7.57 | 12.06 | 22.81 | 31.75 | |||||
Normalized Net Income, 3 Yr. CAGR % | 3.57 | -8.56 | 10.48 | 19.45 | 35.05 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 2.31 | -7.76 | 12.06 | 22.82 | 31.76 | |||||
Accounts Receivable, 3 Yr. CAGR % | -16.27 | -2.29 | 4.04 | 28.76 | 24.25 | |||||
Inventory, 3 Yr. CAGR % | 13.94 | 13.69 | 10.28 | 0.58 | 3.34 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 5.32 | 1.7 | -3.82 | -1.76 | 3.05 | |||||
Total Assets, 3 Yr. CAGR % | -0.39 | 1.36 | 3.94 | 7.07 | 9.98 | |||||
Tangible Book Value, 3 Yr. CAGR % | 21.98 | 6.95 | 20.13 | 16.83 | 24.37 | |||||
Common Equity, 3 Yr. CAGR % | 7.68 | 2.86 | 8.03 | 8.17 | 12.39 | |||||
Cash From Operations, 3 Yr. CAGR % | 18.4 | -12.42 | 24.21 | 4.42 | 15.41 | |||||
Capital Expenditures, 3 Yr. CAGR % | -12.43 | -13.27 | -5.47 | 12.72 | 30.67 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 44.1 | -12.66 | 43.96 | 6.31 | 22.35 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 41.53 | -13.62 | 36.25 | 5.15 | 20.34 | |||||
Dividend Per Share, 3 Yr. CAGR % | 100 | -5.9 | 0 | -4.35 | 11.87 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.6 | 5.45 | 8.25 | 8.76 | 10.88 | |||||
Gross Profit, 5 Yr. CAGR % | 3.62 | 3.08 | 5.78 | 10.05 | 12.42 | |||||
EBITDA, 5 Yr. CAGR % | 6.74 | -1.27 | 2.6 | 9.64 | 15.49 | |||||
EBITA, 5 Yr. CAGR % | 7.3 | -2.28 | 2.96 | 10.59 | 17.36 | |||||
EBIT, 5 Yr. CAGR % | 7.35 | -2.24 | 2.97 | 10.59 | 17.36 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 20.9 | -4.86 | 6.03 | 13.32 | 17.9 | |||||
Net Income, 5 Yr. CAGR % | 20.63 | -4.89 | 5.2 | 12.49 | 16.81 | |||||
Normalized Net Income, 5 Yr. CAGR % | 5.94 | -2.96 | 2.21 | 12.19 | 19.38 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 20.62 | -5.09 | 5.19 | 12.35 | 16.81 | |||||
Accounts Receivable, 5 Yr. CAGR % | 0.05 | 4.09 | -3.03 | 5.6 | 17.53 | |||||
Inventory, 5 Yr. CAGR % | 8.53 | 8.64 | 9.89 | 6.98 | 7.83 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.23 | 1.52 | 1.62 | 1.47 | -0.55 | |||||
Total Assets, 5 Yr. CAGR % | 2.02 | 1.77 | 0.82 | 4.33 | 7.94 | |||||
Tangible Book Value, 5 Yr. CAGR % | 42.3 | 17.02 | 16.58 | 13.74 | 23.56 | |||||
Common Equity, 5 Yr. CAGR % | 9.64 | 5.8 | 6.25 | 6.39 | 10.78 | |||||
Cash From Operations, 5 Yr. CAGR % | 15.91 | 4.4 | 6.28 | 8.72 | 12.67 | |||||
Capital Expenditures, 5 Yr. CAGR % | -1.66 | -14.71 | -1.66 | -1.47 | 6.71 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 8.68 | 19.49 | 19.02 | 15.2 | 20.97 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 9.5 | 24.04 | 17.61 | 13.13 | 16.63 | |||||
Dividend Per Share, 5 Yr. CAGR % | 9.86 | -3.58 | 43.1 | 3.13 | 3.13 |
- Stock Market
- Equities
- JYOTHYLAB Stock
- Financials Jyothy Labs Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















